Company news

Niagen Bioscience, Inc. news in 2020

Niagen Bioscience, Inc.'s news releases, calls and decks from 2020, newest first.

View company

ChromaDex to Present at Benzinga’s Inaugural Small Cap Conference in December 2020

December 1, 2020

ChromaDex Announces New Clinical Trial to Investigate Niagen® and Milk Production Among Mothers in the Neonatal Intensive Care Unit (NICU)

November 16, 2020

ChromaDex and Watsons Launch New TRU NIAGEN® EX Stick Packs in Hong Kong, Expanding Product Line and Advancing Global Retail Partnership

November 8, 2020

ChromaDex Corporation Reports Third Quarter 2020 Financial Results

November 3, 2020

ChromaDex to Report Third Quarter 2020 Financial Results on Wednesday, November 4, 2020

October 27, 2020

ChromaDex Announces Study Results Showing Nutritional Protocol Including Nicotinamide Riboside Plus Standard of Care Reduces Recovery Time in COVID-19 Patients by Nearly 30%

October 5, 2020

New Preclinical Study Finds Niagen® Prevents Light-Induced Retinal Damage in Mice

September 8, 2020

ChromaDex to Present at the LD 500 Virtual Investor Conference

August 25, 2020

New Pilot Study Indicates Niagen® May Reduce Inflammatory Cytokines in Stage D Heart Failure Patients

August 17, 2020

ChromaDex to Report Second Quarter 2020 Financial Results on Thursday, August 6, 2020

July 27, 2020

ChromaDex External Research Program (CERP™) Achieves 200th Material Transfer Agreement for Niagen® (Nicotinamide Riboside) Research

July 13, 2020

ChromaDex Announces New Study Results Highlighting Promising Anti-Viral Effects of Niagen® in Coronavirus Cell Model

July 8, 2020

New Preclinical Findings Suggest Boosting NAD+ with Niagen® Holds Potential for Slowing Aging Process and Reducing Metabolic Damage

June 29, 2020

ChromaDex Research & Development Facility Earns ISO/IEC 17025: 2017 Accreditation

June 16, 2020

ChromaDex to Present at June 2020 Lytham Partners Virtual Investor Growth Conference

June 15, 2020

ChromaDex to Host Symposium on NAD+ in Human Health and Disease at NUTRITION 2020 LIVE ONLINE Annual Meeting

May 31, 2020

ChromaDex to Participate in Panel on Master Files for Dietary Supplements Hosted by the American Conference Institute (ACI) and Council for Responsible Nutrition (CRN)

May 26, 2020

ChromaDex Chief Scientific Advisor Dr. Charles Brenner Receives 2020 National Scientific Achievement Award from the American Society for Nutrition

May 20, 2020

ChromaDex Corporation Reports First Quarter 2020 Financial Results

May 10, 2020

Ninth Published Human Trial on Niagen® Nicotinamide Riboside (NR) Shows Increase in NAD+ Levels, Additional Research Highlights Downfalls of Nicotinamide Mononucleotide (NMN)

May 5, 2020

ChromaDex to Report First Quarter 2020 Financial Results on Monday, May 11, 2020

April 30, 2020

Cellular Health Market Leader Tru Niagen® to Launch in U.K. Online and in Retail Stores Exclusively with Superdrug, Expanding Global Retail Partnership Between ChromaDex and A.S. Watson Group

April 27, 2020

ChromaDex Commits to COVID-19 Research Following Promising Initial Preclinical Findings Showing Viral Infections Deplete NAD and SARS-CoV-2-Infected Cells Activate NAD Defense Pathway That Utilizes Nicotinamide Riboside (NR)

April 19, 2020

Elysium Health, Inc. Loses Appeal of Patent Challenge Decision, Upholding Validity of ChromaDex Intellectual Property

April 13, 2020

Cellular Health Market Leader Tru Niagen® Launches Online in Australia

March 22, 2020

ChromaDex corporation reports 2019 financial results

March 9, 2020

New Niagen® Nicotinamide Riboside (NR) Study Deepens Understanding of NAD Decline and Hearing Loss in Animal Model

February 26, 2020

ChromaDex to Report Fourth Quarter 2019 Financial Results on Tuesday, March 10, 2020

February 24, 2020

ChromaDex Partners with Personalized Nutrition Company, Persona Nutrition, Expanding Global Partnership with Nestlé Health Science

February 11, 2020

ChromaDex Launches New Line of High Purity Cannabinoid (CBD) Reference Standards Available for Research and Analytical Testing Worldwide

February 2, 2020

ChromaDex Achieves New Regulatory Milestones in the European Union & Australia

January 14, 2020

Calls in 2020

Decks in 2020